Orphazyme A/S
DelistedCIK 1764791fmd_08NCXNQ626AMKJC9PA0C9XA5KQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2021, 4 periods
Latest annual · FY2021
Millions- Total revenues
- 36
- Operating income
- (633)
- Net income
- (627)
- Free cash flow
- (603)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- n/m
Orphazyme A/S financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | DKK 36.2 million | DKK 0 | 20-F 2022-06-28 · proof | |
| Operating income | -DKK 633.3 million | -DKK 608.5 million | 20-F 2022-06-28 · proof | |
| Net income | -DKK 626.5 million | -DKK 633.2 million | 20-F 2022-06-28 · proof | |
| Cash from operating activities | -DKK 602.6 million | -DKK 539.1 million | 20-F 2022-06-28 · proof | |
| Free cash flow | -DKK 602.7 million | -DKK 541.4 million | 20-F 2022-06-28 · proof | |
| Total assets | DKK 173.2 million | DKK 822.5 million | -78.9% | 20-F 2022-06-28 · proof |
| Total liabilities | DKK 163.9 million | DKK 202 million | -18.9% | 20-F 2022-06-28 · proof |
| Cash and cash equivalents | DKK 102.3 million | DKK 726.9 million | -85.9% | 20-F 2022-06-28 · proof |
| Total debt | DKK 33.5 million | DKK 57.2 million | -41.5% | 20-F 2022-06-28 · proof |
- What was Orphazyme A/S's revenue in fiscal 2021?
- Orphazyme A/S reported revenue of DKK 36.2 million for fiscal 2021 (the year ended Dec 31, 2021), against DKK 0 the year before. Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What was Orphazyme A/S's operating income in fiscal 2021?
- Orphazyme A/S reported operating income of -DKK 633.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 608.5 million the year before. Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What was Orphazyme A/S's net income in fiscal 2021?
- Orphazyme A/S reported net income of -DKK 626.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 633.2 million the year before. Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What was Orphazyme A/S's cash from operating activities in fiscal 2021?
- Orphazyme A/S reported cash from operating activities of -DKK 602.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 539.1 million the year before. Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What was Orphazyme A/S's free cash flow in fiscal 2021?
- Orphazyme A/S reported free cash flow of -DKK 602.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 541.4 million the year before. Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What are Orphazyme A/S's total assets?
- As of Dec 31, 2021, Orphazyme A/S reported total assets of DKK 173.2 million, against DKK 822.5 million a year earlier (-78.9%). Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What are Orphazyme A/S's total liabilities?
- As of Dec 31, 2021, Orphazyme A/S reported total liabilities of DKK 163.9 million, against DKK 202 million a year earlier (-18.9%). Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What are Orphazyme A/S's cash and cash equivalents?
- As of Dec 31, 2021, Orphazyme A/S reported cash and cash equivalents of DKK 102.3 million, against DKK 726.9 million a year earlier (-85.9%). Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
- What is Orphazyme A/S's total debt?
- As of Dec 31, 2021, Orphazyme A/S reported total debt of DKK 33.5 million, against DKK 57.2 million a year earlier (-41.5%). Source: the 20-F filed with the SEC on Jun 28, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1764791&period_type=annual&limit=5"Information only, not investment advice.